alcohol; pegfilgrastim; pentoxifylline; prednisolone; acute kidney failure; adult; adverse drug reaction; clinical article; clinical trial; conference abstract; controlled study; coronavirus disease 2019; discriminant analysis; drug efficacy; drug safety; drug therapy; female; health care quality; hepatic encephalopathy; hepatitis A; hepatorenal syndrome; human; incidence; leukocyte count; male; multicenter study; open study; outcome assessment; pandemic; phase 2 clinical trial; physician; prospective study; randomized controlled trial; side effect; treatment failure; United States